Early Adoption of Thyroid Radiofrequency Ablation in Canada: Physician Experiences, Barriers, and Facilitators to Implementation.

Importance: Thyroid radiofrequency ablation (RFA) is a minimally invasive alternative to surgery for thyroid nodules. Despite strong international evidence, thyroid RFA was only approved by Health Canada in April 2023. Understanding the experiences of early adopters can inform the broader adoption o...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Otolaryngology -- Head & Neck Surgery Vol. 55; pp. 1 - 10
Autores principales: Gao, Harrison, Liu, David, Levy, Ben B., Shapiro, Justin, Higgins, Kevin M., Khalil, Diana E., Cottrill, Elizabeth E., Poon, Courtney, Kamalraj, Pabiththa, Philteos, Justine, Eskander, Antoine
Formato: research tables/charts Journal Article
Publicado: Sage Publications Inc. 06/18/2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194727447&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 194727447
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07077270
        8B4Q
      jtl: Journal of Otolaryngology -- Head & Neck Surgery
      issn: 07077270
      maglogo: N
    pubinfo:
      dt: 06/18/2026
      vid: 55
      pid: 344
      pub: Sage Publications Inc.
      place: Thousand Oaks, California
    artinfo:
      ui:
        194727447
        194727447
        194727447
        10.1177/19160216261451820
        194727447
      ppf: 1
      ppct: 9
      formats:
      tig:
        atl: Early Adoption of Thyroid Radiofrequency Ablation in Canada: Physician Experiences, Barriers, and Facilitators to Implementation.
      aug:
        au:
          Gao, Harrison
          Liu, David
          Levy, Ben B.
          Shapiro, Justin
          Higgins, Kevin M.
          Khalil, Diana E.
          Cottrill, Elizabeth E.
          Poon, Courtney
          Kamalraj, Pabiththa
          Philteos, Justine
          Eskander, Antoine
        affil: Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
      sug:
        subj:
          Radiofrequency Ablation Canada
          Thyroid Nodule Therapy
          Implementation Science
          Physician Attitudes Evaluation
          Health Services Accessibility Evaluation
          Funding Source
          Canada
          Human
          Descriptive Statistics
          Otolaryngologists
          Surgeons
          Radiologists
          Endocrinologists
          Purposive Sample
          Multimethod Studies
          Semi-Structured Interview
          Qualitative Studies
          Descriptive Research
          Pilot Studies
          Quantitative Studies
          Mann-Whitney U Test
          Data Analysis Software
          Thematic Analysis
          Interview Guides
      ab: Importance: Thyroid radiofrequency ablation (RFA) is a minimally invasive alternative to surgery for thyroid nodules. Despite strong international evidence, thyroid RFA was only approved by Health Canada in April 2023. Understanding the experiences of early adopters can inform the broader adoption of RFA in Canada and other healthcare systems. Objective: To describe the implementation experiences of early adopters of thyroid RFA in Canada and identify barriers and facilitators to adoption. Design: Multiple methods. Setting: All 8 listed RFA facilities in Canada. Participants: Physicians performing thyroid RFA (n = 9). Main Outcome Measures: Survey and semi-structured interviews. Results: Most participants reported low RFA volumes (median [IQR] = 2.0 [0.6-3.0] cases/month) and short wait times (1.5 [1.0-2.0] months). For thyroid surgery on similar nodules, participants performed higher volumes (7.5 [6.0-10.2] cases/month, P =.01) and had longer wait times (6.0 [5.5-8.5] months, P <.01). Four major themes emerged: (1) financial barriers and inequity; (2) impact on the healthcare system; (3) learning curve; and (4) motivators and facilitators. Financial barriers were driven by the RFA generator ($40 500 CAD) and single-use probes ($1500-$2500 CAD). RFA was funded privately out-of-pocket in most physician practices (n = 7) and rarely publicly covered (n = 2). Motivators and facilitators included patient-centred benefits, professional development, institutional support, and potential resource savings. Conclusions: Thyroid RFA adoption in Canada is in its infancy, characterized by low procedural volumes, few providers, and geographical disparities. Early adopters reported positive experiences with RFA. However, inconsistent funding models, billing codes, and policy frameworks have resulted in inequitable access for patients. Relevance: Many healthcare systems are in the early stages of RFA adoption, similar to Canada. This study identifies key experiences, barriers, and facilitators applicable to physicians, leaders, and policymakers globally who are interested in adopting RFA.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N